Paul Barclay
Company: Leo Pharma
Job title: Vice President, Global Program Head, Global Development
Seminars:
Closing Q&A Panel 5:40 pm
day: Day One
Updates on Non-Oral JAKi Therapy: Unique Challenges & Interest 9:00 am
Outlining current challenges and opportunities with alternative JAKi application Sharing insights from multidisciplinary backgrounds and application experience Speculating on the upcoming therapeutic landscape and potential for alternative JAKi interventionRead more
day: Day Two
Topical JAK Inhibitor Development – the Promise & the Challenges 4:50 pm
Exploring how efficacy compares with oral JAKs Recalling what methods are available to assess skin penetration and target occupancy Detailing whether lower systemic exposure leads to a better safety profile Sharing the regulatory challengesRead more
day: Day One